🏛️ Verified NIH Record • Updated 2026-08-03
CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD (NCT05609916)
🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Baylor College of Medicine
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.
Who can join: Review the eligibility criteria below.
Location: Baylor College of Medicine — Houston, Texas
Age range: 7 Years to 17 Years
🧪 Interventions in This Study
- Cognitive Behavioral Therapy (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Baylor College of Medicine — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 798-3080
Email: eric.storch@bcm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cognitive Behavioral Therapy
- Fear of Recurrence and Stopping Immunotherapy — Pittsburgh, Pennsylvania
Explore by condition: All Cognitive Behavioral Therapy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.